SCHEMBL5508438

SCHEMBL5508438

COCCCC[C@@](O)(c1cccc(Cl)c1)C1CCCN(C(=O)O)C1

nearest known ligand 0.67

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
REN P00797 20/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8271800 0.93 REN (0.67) REN
SCHEMBL973589 0.89 REN (0.66) REN
SCHEMBL973590 0.89 REN (0.66) REN
SCHEMBL5504821 0.89 REN (0.67) REN
SCHEMBL5604427 0.88 REN (0.54) REN
SCHEMBL5509469 0.88 REN (0.54) REN
SCHEMBL1866233 0.88 REN (0.57) REN
SCHEMBL5505737 0.88 REN (0.53) REN
SCHEMBL27689723 0.88 REN (0.53) REN
SCHEMBL5505732 0.88 REN (0.53) REN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007117560-A2 PIPERIDINE AND MORPHOLINE RENIN INHIBITORS VITAE PHARMACEUTICALS, INC. (US) 2007-10-18 WO disclosed
EP-1807078-A1 DIAMINOALKANE ASPARTIC PROTEASE INHIBITORS Vitae Pharmaceuticals, Inc. (US) 2007-07-18 EP disclosed
WO-2006042150-A1 DIAMINOALKANE ASPARTIC PROTEASE INHIBITORS VITAE PHARMACEUTICALS, INC. (US) 2006-04-20 WO disclosed